Correction: Urinary Cotinine and Cotinine + Trans-3'-Hydroxycotinine (TNE-2) Cut-points for Distinguishing Tobacco Use from Nonuse in the United States: PATH Study (2013-2014).

IF 3.7 3区医学 Q2 ONCOLOGY

Cancer Epidemiology Biomarkers & Prevention Pub Date : 2025-01-09 DOI:10.1158/1055-9965.EPI-24-1668

Kathryn C Edwards, Tasmia Naz, Cassandra A Stanton, Maciej L Goniewicz, Dorothy K Hatsukami, Danielle M Smith, Lanqing Wang, Andrea Villanti, Jennifer Pearson, Benjamin C Blount, Maansi Bansal-Travers, June Feng, Raymond Niaura, Michelle T Bover Manderski, Connie S Sosnoff, Cristine D Delnevo, Kara Duffy, Arseima Y Del Valle-Pinero, Brian L Rostron, Colm Everard, Heather L Kimmel, Dana M van Bemmel, Andrew Hyland

引用次数: 0

查看原文本刊更多论文

更正：尿可替宁和可替宁+ Trans-3′-羟基可替宁（TNE-2）在美国区分烟草使用和不使用的临界点：PATH研究（2013-2014）。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cancer Epidemiology Biomarkers & Prevention 医学-公共卫生、环境卫生与职业卫生

CiteScore

6.50

自引率

2.60%

发文量

538

审稿时长

1.6 months

期刊介绍： Cancer Epidemiology, Biomarkers & Prevention publishes original peer-reviewed, population-based research on cancer etiology, prevention, surveillance, and survivorship. The following topics are of special interest: descriptive, analytical, and molecular epidemiology; biomarkers including assay development, validation, and application; chemoprevention and other types of prevention research in the context of descriptive and observational studies; the role of behavioral factors in cancer etiology and prevention; survivorship studies; risk factors; implementation science and cancer care delivery; and the science of cancer health disparities. Besides welcoming manuscripts that address individual subjects in any of the relevant disciplines, CEBP editors encourage the submission of manuscripts with a transdisciplinary approach.